Vitamin Shoppe, Inc. Completes Initial Public Offering

* Reuters is not responsible for the content in this press release.

Mon Nov 2, 2009 4:37pm EST

http://www.businesswire.com/news/home/20091102006461/en

NORTH BERGEN, N.J.--(Business Wire)--
Vitamin Shoppe, Inc. (NYSE:VSI) today announced the closing of its initial
public offering of its common stock, which was priced on October 27 at a public
offering price of $17.00 per share. In connection with the initial public
offering, the underwriters exercised in full their option to purchase an
additional 1,364,411 shares of common stock from the selling stockholders. As a
result, a total of 10,460,488 shares were sold in the initial public offering,
consisting of 7,666,667 shares of common stock sold by Vitamin Shoppe and
2,793,821 shares sold by the selling stockholders. 

Vitamin Shoppe intends to use the net proceeds of approximately $121.2 million
from the offering for the pro rata redemption of approximately $72.5 million of
its outstanding preferred stock, the repurchase of approximately $45.2 million
in aggregate principal amount of its outstanding senior secured notes, and the
payment of offering-related expenses. 

J.P.Morgan, BofA Merrill Lynch and Barclays Capital are acting as joint
book-running managers for the offering. Piper Jaffray, Robert W. Baird & Co. and
Stifel Nicolaus are the co-managers of the offering. 

The public offering is being made only by means of a prospectus, copies of which
may be obtained from either:

 J.P.Morgan                                        
 c/o Broadridge Financial Solutions                
 1155 Long Island Ave                              
 Edgewood, NY 11717                                
 
BofA Merrill Lynch                               
 4 World Financial Center                          
 New York, NY 10080                                
 Attention: Preliminary Prospectus Department      
 Email: Prospectus.Requests@ml.com                 
 
Barclays Capital                                 
 c/o Broadridge Integrated Distribution Services   
 1155 Long Island Avenue                           
 Edgewood, NY 11717                                
 Email: barclaysprospectus@broadridge.com          
                                                   


A registration statement relating to shares of the common stock of Vitamin
Shoppe has been declared effective by the Securities and Exchange Commission.
This press release shall not constitute an offer to sell or a solicitation of an
offer to buy, nor shall there be any sale of these securities in any state or
jurisdiction in which such an offer, solicitation or sale would be unlawful. 

About Vitamin Shoppe, Inc.

Vitamin Shoppe is a specialty retailer and direct marketer of nutritional
products based in North Bergen, New Jersey. The company sells vitamins,
minerals, nutritional supplements, herbs, sports nutrition formulas, homeopathic
remedies, green living products and health and beauty aids to customers located
primarily in the United States.

Investors:
Vitamin Shoppe, Inc.
Michael Archbold, Chief Financial Officer
201-624-3611
ir@vitaminshoppe.com
Media:
Vitamin Shoppe, Inc.
Susan McLaughlin, Director Corporate Communications
201-624-3134
smclaughlin@vitaminshoppe.com
or:
Allison & Partners
Jill Yaffe, 646-428-0602
vitaminshoppe@allisonpr.com



Copyright Business Wire 2009

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.